Updates in Major Depressive Disorder with Insomnia

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/54/f0/ac/54f0ac5d-ba46-f9e7-28b7-672ab0a048c7/mza_5551349009705862383.jpg/600x600bb.jpg

ReachMD CME

ReachMD

404 episodes

1 day ago

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Science

Medicine

RSS

All content for ReachMD CME is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Updates in Major Depressive Disorder with Insomnia

ReachMD CME

2 weeks ago

Updates in Major Depressive Disorder with Insomnia

CME credits: 0.50
Valid until: 07-11-2026
Claim your CME credit at https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/

Approximately 75% to 90% of patients with depression experience insomnia. This means that a very significant portion of individuals struggling with depression also have difficulty sleeping. Join Drs. Michael Thase and Andrew Krystal for this expert discussion to learn about the most recent data presented at the Psych Congress 2025 in San Diego on emerging therapies, such as the selective OX2R antagonists to treat major depressive disorder with insomnia.